Samoud, S.; Zamali, I.; Korbi, F.; Mtiraoui, A.; Ben Hmid, A.; Hannachi, N.; Galai, Y.; Louzir, H.; El Kissi, Y.
High Prevalence of aCL-IgA and aβ2GPI-IgA in Drug-Free Schizophrenia Patients: Evidence of a Potential Autoimmune Link. Antibodies 2024, 13, 92.
https://doi.org/10.3390/antib13040092
AMA Style
Samoud S, Zamali I, Korbi F, Mtiraoui A, Ben Hmid A, Hannachi N, Galai Y, Louzir H, El Kissi Y.
High Prevalence of aCL-IgA and aβ2GPI-IgA in Drug-Free Schizophrenia Patients: Evidence of a Potential Autoimmune Link. Antibodies. 2024; 13(4):92.
https://doi.org/10.3390/antib13040092
Chicago/Turabian Style
Samoud, Samar, Imen Zamali, Fatma Korbi, Ahlem Mtiraoui, Ahlem Ben Hmid, Neila Hannachi, Yousr Galai, Hechmi Louzir, and Yousri El Kissi.
2024. "High Prevalence of aCL-IgA and aβ2GPI-IgA in Drug-Free Schizophrenia Patients: Evidence of a Potential Autoimmune Link" Antibodies 13, no. 4: 92.
https://doi.org/10.3390/antib13040092
APA Style
Samoud, S., Zamali, I., Korbi, F., Mtiraoui, A., Ben Hmid, A., Hannachi, N., Galai, Y., Louzir, H., & El Kissi, Y.
(2024). High Prevalence of aCL-IgA and aβ2GPI-IgA in Drug-Free Schizophrenia Patients: Evidence of a Potential Autoimmune Link. Antibodies, 13(4), 92.
https://doi.org/10.3390/antib13040092